logo
Top FDA vaccine expert blasts RFK Jr. as he's forced out

Top FDA vaccine expert blasts RFK Jr. as he's forced out

Independent29-03-2025

A top Federal Drug Administration (FDA) official resigned from his post Friday, marking the third high-ranking employee to leave the agency this year amid a worsening outbreak of measles.
Dr Peter Marks, the director for the agency's Center for Biologics Evaluation and Research, submitted his resignation letter to FDA Acting Commissioner Sara Brenner, citing Health and Human Services Secretary Robert F Kennedy's 'misinformation and lies' on vaccines.
'It has become clear that truth and transparency are not desired by the secretary,' Marks wrote. 'Efforts currently being advanced by some on the adverse health effects of vaccination are concerning.'
Marks joined the FDA in 2012 as the center's deputy director, before becoming director in 2016. His roles involved enhancing the safety of the country's blood supply, advancing cell and gene therapy and responding to public health emergencies.
He spearheaded Operation Warp Speed during the COVID-19 pandemic, a federal effort dedicated to vaccinating against the virus. Despite his work, he was offered the chance to resign or be fired, two anonymous sources told The Washington Post.
Earlier this week, the same outlet reported that David Geier, a vaccine skeptic, had been tapped to lead a study of possible links between autism and immunizations.
Marks raised concerns about the undermining of vaccine science, particularly relating to measles outbreaks in the US. Kennedy has said that receiving a measles vaccine is a personal choice, and has boosted the use of vitamin A as a treatment. While vitamin A can be beneficial for someone who has become unwell, experts say it is not a replacement for vaccination to prevent measles.
'It is unconscionable with measles outbreaks to not have a full-throated endorsement of measles vaccinations,' Marks told The Post.
Measles had been eliminated from the US since 2000. Last year, it killed more than 100,000 unvaccinated children in Africa and Asia.
Marks said he worked to address Kennedy's concerns over vaccine development by hearing from the public and implementing various public meetings and engagements with the National Academy of Sciences, Engineering and Medicine.
'Though rarely followed by a single fever-related seizure, or very rarely by allergic reactions or blood clotting disorders, the vaccine very simply does not cause autism, nor is it associated with encephalitis or death,' Marks said of the measles vaccine. 'It does, however, protect against a potential devastating consequence of prior measles infection.'
Though Marks said he will no longer be part of the agency's mission, he hopes that in the coming years that 'the unprecedented assault on scientific truth that has adversely impacted public health in our nation comes to an end so that the citizens of our country can fully benefit from the breadth of advances in medical science.'
Marks is the third top leader at the FDA to resign this year. The agency's drug chief Patrizia Cavazzoni and human foods chief Jim Jones also left their posts.
Kennedy was confirmed last month following an at-times heated confirmation hearing.
During the hearing, Kennedy downplayed his opposition to vaccines, telling congressional members he is not anti-vaccine but rather 'pro-safety.'
'I believe that vaccines play a critical role in health care,' he said.
Vermont Senator Bernie Sanders, an Independent, challenged Kennedy, asking him if he agrees with evidence stating vaccines do not cause autism.
Kennedy responded: 'If you show me those studies, I will absolutely —'
Sanders cut him off, saying: 'That is a very troubling response because the studies are there. Your job is to have looked at those studies as an applicant for this job.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Covid Nimbus variant in UK 'causes hospital surge' in some countries
Covid Nimbus variant in UK 'causes hospital surge' in some countries

Daily Mirror

time4 hours ago

  • Daily Mirror

Covid Nimbus variant in UK 'causes hospital surge' in some countries

Health experts have issued 'stay at home' advice and officials said in countries where it is rampant a big increase in serious infections has happened Top health officials have said people should 'stay indoors' if they feel they have Covid symptoms after a new strain was detected in the UK. Worryingly, the UK Health Security Agency (UKHSA) highlighted that in other countries where the new 'Nimbus' variant is widespread, it has led to a big rise in hospitalisations. ‌ In a new blog the UKHSA said the fresh NB.1.8.1 variant spread, is being monitored by the World Health Organisation. ‌ Dr Gayatri Amirthalingam, the Deputy Director at UKHSA, said: "NB.1.8.1 has been detected in small numbers in the UK to date, but international data suggests that it is growing as a proportion of all Covid-19 cases." 'Based on the available information so far however, there is no evidence to suggest that this variant causes more severe disease than previous variants, or that the vaccines in current use will be less effective against it.' The UKHSA added: "NB.1.8.1 has been detected in small numbers in the UK to date, and international data suggests that it is growing as a proportion of all COVID-19 cases. Although cases and hospitalisations are increasing in some countries where NB.1.8.1 is widespread, current data does not indicate that this variant leads to more severe illness than other variants in circulation. "The most important thing to do is to get your vaccination when it is due if you're eligible. It's normal for viruses to mutate and change, and as more data becomes available on this variant we'll have a better understanding of how it interacts with our immune systems and how to optimise our protection, as well as actions we can take to keep the most vulnerable safe and live our lives as normally as possible." With the rise of the Nimbus variant, the UKHSA has issued advice on what people should do if they catch it - including wearing a mask if they go out. ‌ They stated: "If you have symptoms of a respiratory infection, such as COVID-19, and you have a high temperature or do not feel well enough to go to work or carry out normal activities, you should avoid contact with vulnerable people and stay at home if possible." The UKHSA further advised that if a person leaves their home while they have symptoms of a respiratory infection, and you have a high temperature or feel unwell, they should "avoid close contact with anyone who you know is at higher risk of becoming seriously unwell, especially those whose immune system means that they are at higher risk of serious illness, despite vaccination." UKHSA advice on reducing chance of passing on infection to others: Wear a well-fitting face covering made with multiple layers or a surgical face mask Avoid crowded places such as public transport, large social gatherings, or anywhere that is enclosed or poorly ventilated Taking any exercise outdoors in places where you will not have close contact with other people Covering your mouth and nose when you cough or sneeze; wash your hands frequently with soap and water for 20 seconds or use hand sanitiser after coughing, sneezing and blowing your nose and before you eat or handle food; avoid touching your face. For more information and advice, click here. Symptoms include: severe sore throat fatigue mild cough fever muscle aches congestion

Full list of Covid symptoms including three unusual ones as new variant reaches UK
Full list of Covid symptoms including three unusual ones as new variant reaches UK

Wales Online

time5 hours ago

  • Wales Online

Full list of Covid symptoms including three unusual ones as new variant reaches UK

Full list of Covid symptoms including three unusual ones as new variant reaches UK The new Covid variant has spread through several countries and now reached the UK The new strain was first detected in January (Image: Getty Images ) Brits are being warned to watch out for three unusual symptoms that could be a sign of a new Covid strain which has been detected in the UK. These symptoms are not typically associated with the virus and could lead to misdiagnosis. More than five years on from the start of the pandemic, Covid-19 continues to spread globally, with the virus mutating multiple times to produce new variants. The latest strain, NB.1.8.1, has already spread across several countries, with seven cases identified in Northern Ireland. First detected in January, this new strain is a sublineage of the Omicron variant, and the Health Protection Surveillance Centre reports that the number of Covid cases linked to it has jumped from 3.7 per cent to 33.3 per cent in just five weeks. The World Health Organisation has classified NB. 1.8.1 as a "variant under monitoring", due to its rapid global spread, with the strain now accounting for over 10 per cent of sequenced Covid infections worldwide, and dominating in China and Hong Kong. The new Covid variant, also detected in the US and Australia as well as holiday hotspots like Egypt, Thailand, and the Maldives, may be more transmissible than its predecessors, according to Dr Lara Herrero, research leader in virology at Griffith University. Three lesser-known symptoms While coughs, sore throats and loss of taste or smell are familiar signs of Covid, the NB. 1.8.1 strain might bring less recognised symptoms too. Stay informed on the latest health news by signing up to our newsletter here . Article continues below "Reports suggest symptoms of NB.1.8.1 should align closely with other Omicron subvariants," Dr Herrero said, noting that some cases could exhibit gastrointestinal issues. As The Independent highlighted, these could include: Diarrhoea Constipation Nausea This could lead to confusion over whether someone is suffering from Covid or another illness. However, Dr Herrero explained that people may experience typical symptoms such as a sore throat, fatigue, fever, mild cough, muscle aches and nasal congestion alongside the more unusual symptoms. Full list of symptoms a high temperature or shivering (chills) – a high temperature means you feel hot to touch on your chest or back (you do not need to measure your temperature) a new, continuous cough – this means coughing a lot for more than an hour, or 3 or more coughing episodes in 24 hours a loss or change to your sense of smell or taste shortness of breath feeling tired or exhausted an aching body a headache a sore throat a blocked or runny nose loss of appetite diarrhoea feeling sick or being sick If you think you have Covid, NHS advice is to minimise contact with others despite no legal self-isolation requirement, especially if you're displaying symptoms. Article continues below You can continue your usual activities when you feel better or do not have a high temperature. However, if you test positive, you should: Try to stay at home and avoid contact with other people for three days after the day the test was taken if you or your child is under 18 years old – children and young people tend to be infectious for less time than adults Try to stay at home and avoid contact with other people for five days after the day you took your test if you are 18 years old or over Avoid meeting people who are more likely to get seriously ill from infections, such as people with a weakened immune system, for 10 days after the day you took your test

Shock Covid warning: Ultra-catchy 'Nimbus' variant could trigger summer wave amid 97 per cent infection surge
Shock Covid warning: Ultra-catchy 'Nimbus' variant could trigger summer wave amid 97 per cent infection surge

Daily Mail​

time5 hours ago

  • Daily Mail​

Shock Covid warning: Ultra-catchy 'Nimbus' variant could trigger summer wave amid 97 per cent infection surge

A new highly contagious Covid variant could spark a wave of infections this summer, scientists have warned. Dubbed 'Nimbus', the strain is descended from the already super virulent Omicron and has already triggered a surge in cases in China, Singapore and Hong Kong. Data from the UK Health Security Agency (UKHSA) also shows 13 cases of Nimbus, known scientifically as N.B.1.8.1, have already been detected in England. And 25 British samples of the strain have been submitted to an international Covid database since the end of March. However, both figures are likely an underestimation of how far the variant has spread given how testing has been massively reduced from the height of the pandemic. Other UKHSA data show the percentage of people testing positive for Covid has risen to its highest point this year, and is already 97 per cent higher than the level recorded in March. Now, British scientists have warned Nimbus could lead to a surge in Covid cases in a matter of weeks, and have urged the vulnerable to get vaccinated. They warn that many people's immunity to the virus, built up from previous infections and older jabs, has likely faded meaning they could be at higher risk of falling ill. Professor Lawrence Young, a virologist at Warwick University, said Nimbus had the potential to drive a surge in cases as the weather warms up and people become more sociable. 'We are very likely to see a spike of infections over the next couple of months, possibly by later this month or in July. But it's difficult to predict the level of this infection wave,' he told The i Paper. 'Population immunity, either from vaccination or previous infection, is waning and, unlike other respiratory viruses such as flu, the Covid virus continues to spread in hot and humid weather,' he said. He added lab studies suggest Nimbus can infect human cells more efficiently than previous strains, and that it may have increased ability to dodge the immune system, making it more likely to infect people. There is currently no evidence that the strain is more likely to cause severe illness or death in those it infects, compared to previous strains. However, infection with the virus can still be deadly for more vulnerable groups. Covid was a factor in the deaths of just over 300 people in England in May, according to the latest official figures. Nimbus now accounts for 10.7 per cent of Covid infections worldwide, according to the World Health Organisation (WHO), compared to just 2.5 per cent a month prior. Last month the UN-body declared the strain a 'variant under monitoring'. This means that the WHO is tracking the virus, watching for signs it could pose a significant threat to the public which would promote it to a 'variant of concern'. Experts have also said that current Covid vaccines, which have been reformulated to combat Omicron descendants, are expected to remain effective against Nimbus. Symptoms of Nimbus do not appear to differ from other Covid variants and include fatigue, fever, muscle ache and a sore throat. UKHSA data on Covid tests, which goes up to June 1, show 6.1 per cent of the people who were tested that week were positive for the virus, the highest figure for 2025 so far. This is a seven per cent rise from last week's figure and a 97 per cent increase from that recorded at the beginning of March. Dr Gayatri Amirthalingam, UKHSA's deputy director, said the organisation was keeping a close eye on Nimbus. 'UKHSA is monitoring all available data relating to SARS-CoV-2 variants in the UK and abroad, and we continue to publish our findings in our regular Flu and Covid-19 surveillance reports,' she said. 'NB.1.8.1 has been detected in small numbers in the UK to date, but international data suggests that it is growing as a proportion of all Covid-19 cases.' Currently adults over the age of 75, care home residents staff as well as people with a weakened immune system are eligible for a free Covid vaccine in Britain. UKHSA data suggests people who had a Covid jab as part of last spring's booster campaign were 45 per cent less likely to need hospital care for the virus in the weeks that followed compared to the unvaccinated. The agency has urged all people eligible for a vaccine to get jabbed to protect themselves from both NB.1.8.1 and Covid in general.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store